Andrew Lo - 17 Nov 2025 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Reporting relationship: Director
Issuer ticker: BBIO
Reported as of: 17 Nov 2025
Net transaction value: -$6,319,662
SEC form: 4
Accepted by SEC: 19 Nov 2025, 17:08:19 UTC
Prior SEC filing: 24 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Will Solis, Attorney-in-Fact

Key filing fact

Andrew Lo filed Form 4 for BridgeBio Pharma, Inc. (BBIO) on 19 Nov 2025.

Key facts

This page summarizes Andrew Lo's Form 4 filing for BridgeBio Pharma, Inc. (BBIO).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 19 Nov 2025, 17:08.

Change

Previous filing in this sequence was filed on 24 Jun 2025.
Current net transaction value: -$6,319,662.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001679076 Primary reporting owner

Lo Andrew

Relationship: Director
Address: C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR., SUITE 250, PALO ALTO
Signature: /s/ Will Solis, Attorney-in-Fact
Signature date: 19 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BBIO transaction

Common Stock

Sale

Transaction value: $2,451,914
Shares: -36,801
Change %: -67%
Price: $66.63
Shares after: 17,887
Date: 17 Nov 2025
Ownership: Direct
Footnotes: F1

BBIO transaction

Common Stock

Sale

Transaction value: $254,679
Shares: -3,798
Change %: -21%
Price: $67.06
Shares after: 14,089
Date: 17 Nov 2025
Ownership: Direct
Footnotes: F2

BBIO transaction

Common Stock

Sale

Transaction value: $1,566,013
Shares: -24,007
Change %: -23%
Price: $65.23
Shares after: 81,576
Date: 18 Nov 2025
Ownership: By Andrew W. Lo and Nancy N. Lo JTWROS
Footnotes: F3

BBIO transaction

Common Stock

Sale

Transaction value: $2,047,057
Shares: -30,993
Change %: -38%
Price: $66.05
Shares after: 50,583
Date: 18 Nov 2025
Ownership: By Andrew W. Lo and Nancy N. Lo JTWROS
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the weighted average sale price of the shares sold from $65.975 to $66.97 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Footnote F2

Represents the weighted average sale price of the shares sold from $66.975 to $67.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Footnote F3

Represents the weighted average sale price of the shares sold from $64.58 to $65.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Footnote F4

Represents the weighted average sale price of the shares sold from $65.58 to $66.52 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

SEC remarks

Exhibit 24 - Power of Attorney